AOP Health - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAOP Health

AOP Health

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2019-02-15		Polycythemia vera
Sugammadex amomed	Sugammadex	2023-01-10	2026	Neuromuscular blockade

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

coronary disease

,

myocardial ischemia

,

pharmacokinetics

,

,

out-of-hospital cardiac arrest

,

,

coronary artery disease

,

,

supraventricular tachycardia

,

postoperative complications

,

atrial fibrillation

,

cardiac surgical procedures

,

,

low cardiac output

,

,

left ventricular dysfunction

,

ventricular dysfunction

,

ocular hypertension

,

open-angle glaucoma

,

,

Sodium chloride

healthy volunteers/patients

,

,

,

allergic rhinitis

,

,

allergic rhinitis seasonal

,

,

,

pulmonary eosinophilia

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

migraine disorders

,

sleep wake disorders

Albinterferon alfa-2b

kidney neoplasms

,

communicable diseases

,

,

renal cell carcinoma

,

,

brain neoplasms

,

gastrointestinal stromal tumors

,

cholangiocarcinoma

,

primary myelofibrosis

,

,

,

,

hereditary hemorrhagic telangiectasia

,

,

pancreatic neoplasms

,

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

,

myeloid leukemia

,

acquired immunodeficiency syndrome

,

,

,

,

,

neoadjuvant therapy

,

hepatocellular carcinoma

,

liver neoplasms

,

chronic hepatitis d

,

,

liver transplantation

,

,

depressive disorder

,

neoplasm metastasis

,

disease progression

,

,

,

,

chronic hepatitis c

,

chronic hepatitis

,

,

liver cirrhosis

,

,

chronic hepatitis b

,

,

,

,

chronic kidney failure

,

kidney diseases

,

,

insulin resistance

,

,

substance-related disorders

,

intravenous substance abuse

,

,

cutaneous malignant melanoma

,

non-hodgkin lymphoma

,

,

follicular lymphoma

healthy volunteers/patients

,

,

cystic fibrosis

,

rectal neoplasms

,

esophageal neoplasms

,

neoplasm metastasis

,

pancreatic neoplasms

,

disease progression

,

,

,

metabolic diseases

,

diabetes mellitus

,

sleep apnea syndromes

,

metabolic syndrome

,

,

,

stomach neoplasms

,

colonic neoplasms

,

rheumatoid arthritis

,

,

,

non-small-cell lung carcinoma

,

head and neck neoplasms

,

,

respiratory tract diseases

,

germ cell and embryonal neoplasms

,

small cell lung carcinoma

,

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

bronchial diseases

,

neoplasms by histologic type

,

neoplasms by site

,

nerve tissue neoplasms

,

hematologic neoplasms

,

colorectal neoplasms

,

,

postmenopausal osteoporosis

,

,

chronic hepatitis c

,

,

chronic hepatitis

,

,

chronic renal insufficiency

,

vitamin d deficiency

,

renal insufficiency

,

kidney transplantation

,

,

liver cirrhosis

,

,

hepatocellular carcinoma

,

liver neoplasms

,

atrial fibrillation

healthy volunteers/patients

Thromboreductin

essential thrombocythemia

,

,

pulmonary arterial hypertension

,

familial primary pulmonary hypertension

healthy volunteers/patients

,

pharmacokinetics

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use